However, in a number of studies, the expression of VISTA by tumor cells was detected in different proportions of samples in NSCLC [140], hepatocellular carcinoma [141], ovarian and endometrial cancer [142], melanoma, stomach cancer, and breast cancer [143]. This evidence concerns the gene VSIR and hepatocellular carcinoma.